Puretech Health/£PRTC
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Puretech Health
PureTech Health, trading under the ticker PRTC, is a biotechnology company focused on discovering, developing, and commercializing highly differentiated medicines for devastating diseases. Operating within the healthcare sector, the company leverages its deep expertise in the understanding of disease physiology to advance a pipeline of novel therapies addressing serious medical conditions. Founded in 2015, PureTech Health engages in groundbreaking translational research that bridges the gap between innovative biological insights and potential impactful therapies.
Ticker
£PRTC
Sector
Primary listing
LSE
Employees
56
Headquarters
Website
Puretech Health Metrics
BasicAdvanced
£328m
-
-£0.34
-
-
Price and volume
Market cap
£328m
52-week high
£1.48
52-week low
£1.05
Average daily volume
873k
Financial strength
Current ratio
6.587
Quick ratio
6.41
Long term debt to equity
59.38
Total debt to equity
66.494
Interest coverage (TTM)
-2.15%
Profitability
EBITDA (TTM)
-71.236
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-2,355.42%
Operating margin (TTM)
-2,114.75%
Effective tax rate (TTM)
0.76%
Revenue per employee (TTM)
£59,870
Management effectiveness
Return on assets (TTM)
-10.83%
Return on equity (TTM)
-30.85%
Valuation
Price to revenue (TTM)
92.361
Price to book
1.02
Price to tangible book (TTM)
1.03
Price to free cash flow (TTM)
-5.054
Free cash flow yield (TTM)
-19.79%
Free cash flow per share (TTM)
-0.267
Growth
Revenue change (TTM)
-3.50%
Earnings per share change (TTM)
-319.05%
3-year revenue growth (CAGR)
-33.18%
10-year revenue growth (CAGR)
-8.90%
3-year earnings per share growth (CAGR)
36.72%
10-year earnings per share growth (CAGR)
8.02%
What the Analysts think about Puretech Health
Analyst ratings (Buy, Hold, Sell) for Puretech Health stock.
Puretech Health Financial Performance
Revenues and expenses
Puretech Health Earnings Performance
Company profitability
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Puretech Health stock?
Puretech Health (PRTC) has a market cap of £328M as of May 16, 2026.
What is the P/E ratio for Puretech Health stock?
The price to earnings (P/E) ratio for Puretech Health (PRTC) stock is 0 as of May 16, 2026.
Does Puretech Health stock pay dividends?
No, Puretech Health (PRTC) stock does not pay dividends to its shareholders as of May 16, 2026.
When is the next Puretech Health dividend payment date?
Puretech Health (PRTC) stock does not pay dividends to its shareholders.
What is the beta indicator for Puretech Health?
Puretech Health (PRTC) does not currently have a Beta indicator.